Loading organizations...
Loading organizations...
Biological reagents and services for drug discovery research.
HitGen has raised $39.1M across 1 funding round.
HitGen has raised $39.1M in total across 1 funding round.
HitGen has raised $39.1M in total across 1 funding round.
HitGen's investors include Lin Wang, Leadyond Capital.
HitGen has raised $39.1M across 1 funding round. Most recently, it raised $39.1M Series B in May 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 28, 2018 | $39.1M Series B | Lin Wang, Leadyond Capital |